| Roy Douglas Vanderpool, MD | |
|
2552 E. Joyce Blvd., Suite B, Fayetteville, AR 72703-4553 | |
| (479) 571-8585 | |
| (479) 571-4005 |
| Full Name | Roy Douglas Vanderpool |
|---|---|
| Gender | Male |
| Speciality | Plastic Surgery |
| Location | 2552 E. Joyce Blvd., Fayetteville, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962648980 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208200000X | Plastic Surgery | C7986 (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Roy Douglas Vanderpool, MD 2552 E. Joyce Blvd., Suite B, Fayetteville, AR 72703-4553 Ph: (479) 571-8585 | Roy Douglas Vanderpool, MD 2552 E. Joyce Blvd., Suite B, Fayetteville, AR 72703-4553 Ph: (479) 571-8585 |
News Archive
Nordion Inc., a leading provider of products and services to the global health science market, today announced that Theorem Clinical Research, previously Omnicare Clinical Research, a full service Contract Research Organization has been awarded the contract to conduct Nordion's recently announced TheraSphere Phase III clinical trials for the treatment of primary and metastatic liver cancers - STOP-HCC and EPOCH.
Laureate Pharma, Inc., a full-service contract development and manufacturing organization today announced that it has secured $20 million in debt and equity financing to enhance and grow its business.
Researchers from the University of North Carolina at Chapel Hill have identified a key molecular mechanism that may account for the development of cystic fibrosis, which about 1 in 3000 children are born with in the US every year.
Santaris Pharma A/S, a privately-held biopharmaceutical company focused on developing RNA-based drugs targeted to disease-related mRNAs and microRNAs, today announced it has established operations in the United States. Internally and through its partners, the Company has a robust drug development pipeline including programs to treat metabolic disorders, infectious and inflammatory diseases, cancer and rare genetic disorders.
Many times, people with heart disease have few visible symptoms. This is one of the reasons why heart disease is the number one killer for both men and women in America. Saint Louis University and SLUCare offer a non-invasive test that could save your life or the life of someone you love.
› Verified 6 days ago
Dr. Robert Taylor, MD, FACS Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3733 N Business Dr, Suite 102, Fayetteville, AR 72703 Phone: 479-521-1500 Fax: 479-521-5413 |